WO2014209166A1 - Composition and method for improving mobilizational reserves of the body - Google Patents
Composition and method for improving mobilizational reserves of the body Download PDFInfo
- Publication number
- WO2014209166A1 WO2014209166A1 PCT/RU2014/000411 RU2014000411W WO2014209166A1 WO 2014209166 A1 WO2014209166 A1 WO 2014209166A1 RU 2014000411 W RU2014000411 W RU 2014000411W WO 2014209166 A1 WO2014209166 A1 WO 2014209166A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- reserves
- improving
- composition
- mobilizational
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 title claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 6
- 240000006079 Schisandra chinensis Species 0.000 claims description 6
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 claims description 6
- 229940109850 royal jelly Drugs 0.000 claims description 5
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 4
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 4
- 108010087806 Carnosine Proteins 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 229960001948 caffeine Drugs 0.000 claims description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 4
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 4
- 229940044199 carnosine Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 4
- 239000001095 magnesium carbonate Substances 0.000 claims description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000020733 paullinia cupana extract Nutrition 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- -1 royal jelly Chemical compound 0.000 claims 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 11
- 230000036632 reaction speed Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 8
- 241000132456 Haplocarpha Species 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to medicine, in particular to methods for improving mobilization reserves of the body.
- the invention is a method of determining a standard equivalent unit of nutrition in one portion of a suspended composition, which contains 85% of all fruits and vegetables consumed in a particular geographical area; a method of strengthening the basic diet, so that the diet contains a standard equivalent unit of nutrition, presenting at least one serving containing (i) at least one fruit, (and) at least one vegetable; or (iii) at least one fruit or one vegetable; and also a food supplement containing a set of nutritional components, where such a set includes at least one standard equivalent nutritional unit, presented in one serving of a composition containing at least one fruit and at least one vegetable.
- the specified invention contains all components except Chinese magnolia vine, dihydroquercetin and royal jelly.
- US 20070196496 A1, 08/23/2007 which presents an oral drug delivery system, the composition of which can be distinguished by the largest number of matching components (all components except Chinese magnolia vine and dihydroquercetin are included).
- the problem to which the claimed invention is directed is to increase the reaction rate of the athlete and improve the mobilization reserves of the athlete's body.
- the drug is used to activate the internal resources of a sprinter athlete before starting.
- SUBSTITUTE SHEET (RULE 26) conditional signal, which allows it to start faster.
- the improvement is 5%.
- a higher level of the functional state of the organism with a high level of regulation mechanisms is achieved.
- composition to improve the mobilization reserves of the body consisting of Chinese magnolia vine from 20 mg to 100 mg, caffeine from 30 mg to 200 mg, guarana extract from 45 mg to 1500 mg, carnosine from 30 mg to 2000 mg, vitamin B1 from 0.7 mg to 5.0 mg, vitamin B2 from 0.9 mg to 6 mg, vitamin B6 from 1 mg to 6 mg, folic acid from 0.2 mg to 0.6 mg, pantothenic acid from 2.5 mg to 15 mg, vitamin E from 5 mg to 150 mg, biotin from 0.025 mg to 0.15 mg, dihydroquercetin from 10 mg to 100 mg, taurine from 50 mg to 1200 mg, L-carnitine from 30 mgup to 900 mg, choline from 50 mg to 1000 mg, ribose from 20 mg to 1000 mg, vitamin C from 10 mg to 900 mg, magnesium carbonate from 10 mg to 800 mg, royal jelly from 5 mg to 100 mg, glutamine from 50 mg to 1000 mg is administered simultaneously.
- Tests of the drug were carried out according to the methodology for assessing the physical performance of athletes developed by a doctor of medical sciences. Polikarpochkin A.N. Table N ° l - Change in the FS of athletes when taking the drug 02/28/2013
- DM an indicator of dynamometry. With its growth, strength also increases.
- LPSSR an indicator of the latent period of a simple sensorimotor reaction
- CFSM an indicator of the critical frequency of fusion of light flickers
- CFSM critical frequency of light flicker fusion
- the use of the claimed funds is necessary for 0.2 - 1 hour before the start of the athlete. When used in less than 0.2 hours, the drug will not have time to act, if used after more than 1 hour, the drug will weaken. Apply the claimed tool can be immediately or in parts.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine and specifically to methods for improving mobilizational reserves of the body. The aim of the invention is to increase the reaction speed of an athlete and to improve the mobilizational reserves of the body of an athlete.
Description
Композиция и способ для улучшения мобилизационных резервов Composition and method for improving mobilization reserves
организма organism
Изобретение относится к медицине, в частности к способам улучшения мобилизационных резервов организма. The invention relates to medicine, in particular to methods for improving mobilization reserves of the body.
Известен патент US 20120027897 А1, 02.02.2012. Описываемое изобретение представляет способ определения стандартной эквивалентной единицы питания в одной порции взвешенного состава, который содержит 85% всех фруктов и овощей, потребляемых в определенной географической местности; метод укрепления основного рациона питания, так, чтобы в рационе содержалась стандартная эквивалентная единица питания, представления как минимум в одной порции, содержащей (i) минимум один фрукт, (и) минимум один овощ; или (iii) минимум один фрукт или один овощ; а также пищевая добавка, содержащая набор питательных компонентов, где такой набор включает как минимум одну стандартную эквивалентную единицу питания, представленную в одной порции состава, содержащего минимум один фрукт и минимум один овощ. Known patent US 20120027897 A1, 02.02.2012. The invention is a method of determining a standard equivalent unit of nutrition in one portion of a suspended composition, which contains 85% of all fruits and vegetables consumed in a particular geographical area; a method of strengthening the basic diet, so that the diet contains a standard equivalent unit of nutrition, presenting at least one serving containing (i) at least one fruit, (and) at least one vegetable; or (iii) at least one fruit or one vegetable; and also a food supplement containing a set of nutritional components, where such a set includes at least one standard equivalent nutritional unit, presented in one serving of a composition containing at least one fruit and at least one vegetable.
Указанное изобретение содержит все компоненты кроме лимонника китайского, дигидрокверцетина и маточного молочка. The specified invention contains all components except Chinese magnolia vine, dihydroquercetin and royal jelly.
Наиболее близким аналогом является патент US 20070196496 А1, 23.08.2007, в котором представлена система доставки препаратов перорального применения, состав которого можно выделить по наибольшему количеству совпадающих компонентов (в состав входят все компоненты кроме лимонника китайского и дигидрокверцетина). The closest analogue is US 20070196496 A1, 08/23/2007, which presents an oral drug delivery system, the composition of which can be distinguished by the largest number of matching components (all components except Chinese magnolia vine and dihydroquercetin are included).
Задача, на решение которой направлено заявленное изобретение, заключается в повышении скорости реакции спортсмена и улучшения мобилизационных резервов организма спортсмена. The problem to which the claimed invention is directed, is to increase the reaction rate of the athlete and improve the mobilization reserves of the athlete's body.
Препарат используется с целью активации внутренних ресурсов спортсмена-спринтера перед стартом. При применении препарата достигается существенное повышение скорости реакции спортсмена на The drug is used to activate the internal resources of a sprinter athlete before starting. When using the drug, a significant increase in the reaction rate of the athlete to
ЗАМЕНЯЮЩИЙ ЛИСТ (ПРАВИЛО 26)
условный сигнал, что позволяет ему быстрее стартовать. Улучшение составляет 5%. При этом достигается более высокий уровень функционального состояния организма с высоким уровнем работы механизмов регуляции. SUBSTITUTE SHEET (RULE 26) conditional signal, which allows it to start faster. The improvement is 5%. At the same time, a higher level of the functional state of the organism with a high level of regulation mechanisms is achieved.
Данный технический результат достигается посредством того, что прием композиции для улучшения мобилизационных резервов организма, состоящей из лимонника китайского от 20 мг до 100 мг, кофеина от 30 мг до 200 мг, экстракта гуараны от 45 мг до 1500 мг, карнозина от 30 мг до 2000 мг, витамина В1 от 0,7 мг до 5,0 мг, витамина В2 от 0,9 мг до 6 мг, витамина В6 от 1 мг до 6 мг, фолиевой кислоты от 0,2 мг до 0,6 мг, пантотеновой кислоты от 2,5 мг до 15 мг, витамина Е от 5 мг до 150 мг, биотина от 0,025 мг до 0,15 мг, дигидрокверцетина от 10 мг до 100 мг, таурина от 50 мг до 1200 мг, Л- карнитина от 30 мг до 900 мг, холина от 50 мг до 1000 мг, рибозы от 20 мг до 1000 мг, витамина С от 10 мг до 900 мг, магния карбоната от 10 мг до 800 мг, маточного молочка от 5 мг до 100 мг, глутамина от 50 мг до 1000 мг, осуществляется одновременно. This technical result is achieved by the fact that taking the composition to improve the mobilization reserves of the body, consisting of Chinese magnolia vine from 20 mg to 100 mg, caffeine from 30 mg to 200 mg, guarana extract from 45 mg to 1500 mg, carnosine from 30 mg to 2000 mg, vitamin B1 from 0.7 mg to 5.0 mg, vitamin B2 from 0.9 mg to 6 mg, vitamin B6 from 1 mg to 6 mg, folic acid from 0.2 mg to 0.6 mg, pantothenic acid from 2.5 mg to 15 mg, vitamin E from 5 mg to 150 mg, biotin from 0.025 mg to 0.15 mg, dihydroquercetin from 10 mg to 100 mg, taurine from 50 mg to 1200 mg, L-carnitine from 30 mgup to 900 mg, choline from 50 mg to 1000 mg, ribose from 20 mg to 1000 mg, vitamin C from 10 mg to 900 mg, magnesium carbonate from 10 mg to 800 mg, royal jelly from 5 mg to 100 mg, glutamine from 50 mg to 1000 mg is administered simultaneously.
Испытания препарата проводились по методике оценки физической работоспособности спортсменов разработанной д.м.н. Поликарпочкиным А.Н. Таблица N°l - Изменение ФС спортсменов при приеме препарата 28.02.2013 г.
Tests of the drug were carried out according to the methodology for assessing the physical performance of athletes developed by a doctor of medical sciences. Polikarpochkin A.N. Table N ° l - Change in the FS of athletes when taking the drug 02/28/2013
Таблица 1 Table 1
Из данной таблицы видно, что произошли серьезные сдвиги в мобилизации всех ресурсов организма для выполнения физической работы. ДМ - показатель динамометрии. При его росте также возрастает сила . ЛППСР (показатель латентного периода простой сенсомоторной реакции), при его уменьшении - вырастает скорость реакции . Данные показатели имеют очень важное значение для спортсменов, в частности, футболистов, хоккеистов. КЧСМ (показатель критической частоты слияния световых мельканий) - вырос. Это говорит о том, что центральная нервная система мобилизовалась. Человек может быстро принять решение. При этом частота сердечных сокращений и давление упали. Это говорит о том, что организм не подвержен стрессу и все органы работают в нормальном режиме. From this table it is seen that there have been serious shifts in the mobilization of all body resources to perform physical work. DM - an indicator of dynamometry. With its growth, strength also increases. LPSSR (an indicator of the latent period of a simple sensorimotor reaction), with its decrease, the reaction rate increases. These indicators are very important for athletes, in particular, football players, hockey players. CFSM (an indicator of the critical frequency of fusion of light flickers) - increased. This suggests that the central nervous system has mobilized. A person can quickly make a decision. At the same time, heart rate and pressure fell. This suggests that the body is not subject to stress and all organs are working in normal mode.
Результаты обследования спортсменов. Results of the survey of athletes.
По результатам обследований можно отметить не очевидные тенденции в положительных изменениях функционального состояния (ФС) спортсменов по данным некоторых показателей: According to the survey results, not obvious trends in positive changes in the functional state (FS) of athletes according to some indicators can be noted:
1) Снижение систолического и диастолического давления. 1) Decrease in systolic and diastolic pressure.
2) Улучшение показателя критическая частота слияния световых мельканий (КЧСМ), который свидетельствует о состоянии зрительного анализатора в коре головного мозга у спортсмена. Чем выше данный показатель, тем быстрее спортсмен может выполнить команду «СТАРТ» и выиграть «касание» или «финишный рывок». 2) Improvement in the critical frequency of light flicker fusion (CFSM), which indicates the state of the visual analyzer in the cerebral cortex in an athlete. The higher this indicator, the faster the athlete can execute the “START” command and win “touch” or “finish spurt”.
3) Улучшение показателя удержания статической нагрузки субмаксимальной мощности по данным показателя ДМ у спортсменов. Данный показатель свидетельствует о состоянии двигательного анализатора в коре головного мозга. Чем он больше, тем лучше, т.е. повышается выносливость спортсмена на нагрузку. 3) Improvement in the retention of static load of submaximal power according to the DM in athletes. This indicator indicates the state of the motor analyzer in the cerebral cortex. The larger it is, the better, i.e. increases the endurance of the athlete to the load.
ЗАМЕНЯЮЩИЙ ЛИСТ (ПРАВИЛО 26)
Индекс ФОН свидетельствует о показателях спортсмена до применения заявляемого средства, индекс ОПЫТ - о показателях спортсмена через 30 минут - 1 час после приема заявляемого средства. SUBSTITUTE SHEET (RULE 26) The BACKGROUND index indicates the performance of the athlete before using the claimed drug, the EXPERIENCE index - the performance of the athlete in 30 minutes - 1 hour after taking the proposed drug.
Данные отражены в таблице 2: The data are shown in table 2:
Применение заявляемого средства необходимо за 0,2 - 1 час до старта спортсмена. При применении менее чем за 0,2 ч препарат не успеет подействовать, при применении более чем через 1 ч - действие препарат ослабнет. Применять заявляемое средство можно сразу или по частям. The use of the claimed funds is necessary for 0.2 - 1 hour before the start of the athlete. When used in less than 0.2 hours, the drug will not have time to act, if used after more than 1 hour, the drug will weaken. Apply the claimed tool can be immediately or in parts.
Таким образом, вышеизложенные сведения свидетельствуют о выполнении при использовании заявленного технического решения следующей совокупности условий: Thus, the above information indicates the fulfillment of the following set of conditions when using the claimed technical solution:
- объект, воплощающий заявленное техническое решение, при его осуществлении предназначен для использования в области медицины;
- для заявленного объекта в том виде, как он охарактеризован в независимом пункте формулы изобретения, подтверждена возможность его осуществления с помощью вышеописанных в материалах заявки известных из уровня техники на дату приоритета средств и методов; - an object embodying the claimed technical solution, when implemented, is intended for use in the field of medicine; - for the claimed object in the form described in the independent claim, the possibility of its implementation using the means and methods known from the prior art on the priority date on the priority date has been confirmed;
- объект, воплощающий заявленное техническое решение, при его осуществлении способен обеспечить достижение усматриваемого заявителем технического результата. - the object embodying the claimed technical solution, when implemented, is able to ensure the achievement of the technical result perceived by the applicant.
Следовательно, заявленный объект соответствуют требованиям условиям патентоспособности «новизна», «изобретательский уровень» и «промышленная применимость» по действующему законодательству.
Therefore, the claimed subject matter meets the requirements of patentability “novelty”, “inventive step” and “industrial applicability” under applicable law.
Claims
1. Композиция для улучшения мобилизационных резервов организма, состоящая из лимонника китайского от 20 мг до 100 мг, кофеина от 30 мг до 200 мг, экстракта гуараны от 45 мг до 1500 мг, карнозина от 30 мг до 2000 мг, витамина В 1 от 0,7 мг до 5,0 мг, витамина В2 от 0,9 мг до 6 мг, витамина В6 от 1 мг до 6 мг, фолиевой кислоты от 0,2 мг до 0,6 мг, пантотеновой кислоты от 2,5 мг до 15 мг, витамина Е от 5 мг до 150 мг, биотина от 0,025 мг до 0,15 мг, дигидрокверцетина от 10 мг до 100 мг, таурина от 50 мг до 1200 мг, Л-карнитина от 30 мг до 900 мг, холина от 50 мг до 1000 мг, рибозы от 20 мг до 1000 мг, витамина С от 10 мг до 900 мг, магния карбоната от 10 мг до 800 мг, маточного молочка от 5 мг до 100 мг, глутамина от 50 мг до 1000 мг. 1. Composition for improving mobilization reserves of the body, consisting of Chinese magnolia vine from 20 mg to 100 mg, caffeine from 30 mg to 200 mg, guarana extract from 45 mg to 1500 mg, carnosine from 30 mg to 2000 mg, vitamin B 1 from 0 7 mg to 5.0 mg, vitamin B2 from 0.9 mg to 6 mg, vitamin B6 from 1 mg to 6 mg, folic acid from 0.2 mg to 0.6 mg, pantothenic acid from 2.5 mg to 15 mg, vitamin E from 5 mg to 150 mg, biotin from 0.025 mg to 0.15 mg, dihydroquercetin from 10 mg to 100 mg, taurine from 50 mg to 1200 mg, L-carnitine from 30 mg to 900 mg, choline from 50 mg to 1000 mg, ribose from 20 mg to 1000 mg, vitamin C from 10 mg to 900 mg, magnesium carbonate from 10 mg to 800 mg, royal jelly from 5 mg to 100 mg, glutamine from 50 mg to 1000 mg.
2. Композиция по п. 1, отличающаяся тем, что выполнена в порошкообразном, таблетированном или капсулированном виде. 2. The composition according to p. 1, characterized in that it is made in powder, tablet or capsule form.
3. Способ улучшения мобилизационных резервов организма, включающий прием лимонника китайского от 20 мг до 100 мг, кофеина от 30 мг до 200 мг, экстракта гуараны от 45 мг до 1500 мг, карнозина от 30 мг до 2000 мг, витамина В1 от 0,7 мг до 5,0 мг, витамина В2 от 0,9 мг до 6 мг, витамина В6 от 1 мг до 6 мг, фолиевой кислоты от 0,2 мг до 0,6 мг, пантотеновой кислоты от 2,5 мг до 15 мг, витамина Е от 5 мг до 150 мг, биотина от 0,025 мг до 0,15 мг, дигидрокверцетина от 10 мг до 100 мг, таурина от 50 мг до 1200 мг, Л-карнитина от 30 мг до 900 мг, холина от 50 мг до 1000 мг, рибозы от 20 мг до 1000 мг, витамина С от 10 мг до 900 мг, магния карбоната от 10 мг до 800 мг, маточного молочка от 5 мг до 100 мг, глутамина от 50 мг до 1000 мг. 3. A method for improving the mobilization reserves of the body, including taking Chinese magnolia vine from 20 mg to 100 mg, caffeine from 30 mg to 200 mg, guarana extract from 45 mg to 1500 mg, carnosine from 30 mg to 2000 mg, vitamin B1 from 0.7 mg to 5.0 mg, vitamin B2 from 0.9 mg to 6 mg, vitamin B6 from 1 mg to 6 mg, folic acid from 0.2 mg to 0.6 mg, pantothenic acid from 2.5 mg to 15 mg Vitamin E from 5 mg to 150 mg, Biotin from 0.025 mg to 0.15 mg, Dihydroquercetin from 10 mg to 100 mg, Taurine from 50 mg to 1200 mg, L-Carnitine from 30 mg to 900 mg, Choline from 50 mg up to 1000 mg, ribose from 20 mg to 1000 mg, vitamin C from 10 mg d about 900 mg, magnesium carbonate from 10 mg to 800 mg, royal jelly from 5 mg to 100 mg, glutamine from 50 mg to 1000 mg.
4. Способ по п. 3, отличающийся тем, что лимонник китайский, кофеин, экстракт гуараны, карнозин, витамин В1 , витамин В2, витамин В6, фолиевая кислота, пантотеновая кислота, витамин Е, биотин, дигидрокверцетин, таурин, Л-карнитин, холин, рибоза, витамин С, магния карбонат, маточное молочко, глутамин поступают в организм одновременно.
4. The method according to p. 3, characterized in that the magnolia vine is Chinese, caffeine, guarana extract, carnosine, vitamin B1, vitamin B2, vitamin B6, folic acid, pantothenic acid, vitamin E, biotin, dihydroquercetin, taurine, L-carnitine, choline, ribose, vitamin C, magnesium carbonate, royal jelly, glutamine enter the body at the same time.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201510487A UA114965C2 (en) | 2013-06-28 | 2014-06-04 | Composition and method for improving mobilizational reserves of the body |
| EA201500990A EA027191B1 (en) | 2013-06-28 | 2014-06-04 | Composition and method for improving mobilizational reserves of the body |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2013129539/13A RU2536447C1 (en) | 2013-06-28 | 2013-06-28 | Composition and method for improving mobilisation body reserves |
| RU2013129539 | 2013-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014209166A1 true WO2014209166A1 (en) | 2014-12-31 |
Family
ID=52142359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2014/000411 WO2014209166A1 (en) | 2013-06-28 | 2014-06-04 | Composition and method for improving mobilizational reserves of the body |
Country Status (4)
| Country | Link |
|---|---|
| EA (1) | EA027191B1 (en) |
| RU (1) | RU2536447C1 (en) |
| UA (1) | UA114965C2 (en) |
| WO (1) | WO2014209166A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2741079C1 (en) * | 2020-04-06 | 2021-01-22 | Общество С Ограниченной Ответственностью "Технологии Дкв" | Prebio dkv food additive |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2096974C1 (en) * | 1995-06-28 | 1997-11-27 | Чепурной Иван Петрович | Method for correcting carbohydrate compound of food products of general and special purpose (versions) |
| RU2312522C2 (en) * | 2001-09-27 | 2007-12-20 | Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх | Mixture of food microelements containing bases |
| RU2419362C1 (en) * | 2009-11-16 | 2011-05-27 | Закрытое акционерное общество "Академия-Т" | Antioxidant complex |
| RU2464996C1 (en) * | 2011-05-05 | 2012-10-27 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Composition showing restorative, general tonic and antidepressant action |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2473359C2 (en) * | 2011-02-24 | 2013-01-27 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Composition for increasing working performance of sportsmen (versions) |
| RU2468812C2 (en) * | 2011-02-24 | 2012-12-10 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Agent possessing adaptogenic, tonic and general tonic action, and method for preparing it |
-
2013
- 2013-06-28 RU RU2013129539/13A patent/RU2536447C1/en active
-
2014
- 2014-06-04 UA UAA201510487A patent/UA114965C2/en unknown
- 2014-06-04 EA EA201500990A patent/EA027191B1/en unknown
- 2014-06-04 WO PCT/RU2014/000411 patent/WO2014209166A1/en active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2096974C1 (en) * | 1995-06-28 | 1997-11-27 | Чепурной Иван Петрович | Method for correcting carbohydrate compound of food products of general and special purpose (versions) |
| RU2312522C2 (en) * | 2001-09-27 | 2007-12-20 | Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх | Mixture of food microelements containing bases |
| RU2419362C1 (en) * | 2009-11-16 | 2011-05-27 | Закрытое акционерное общество "Академия-Т" | Antioxidant complex |
| RU2464996C1 (en) * | 2011-05-05 | 2012-10-27 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Composition showing restorative, general tonic and antidepressant action |
Non-Patent Citations (2)
| Title |
|---|
| BORISOVA O.O.: "Pitanie sportsmenov: zarubezhnyi opyt i prakticheskie rekomendatsii, izd-vo", FIZKULTURA I SPORT, 2007, pages 62 - 63 , 72, 75 * |
| VOLKOV N.I. ET AL.: "Biologicheski aktivnye pischevye dobavki v spetsializirovannom pitanii sportsmenov, izd-vo", FIZKULTURA I SPORT, SPORTAKADEMPRESS, 2005, pages 28 - 35 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EA027191B1 (en) | 2017-06-30 |
| RU2536447C1 (en) | 2014-12-27 |
| EA201500990A1 (en) | 2016-05-31 |
| UA114965C2 (en) | 2017-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wirnitzer | Vegan diet in sports and exercise—Health benefits and advantages to athletes and physically active people: A narrative review | |
| Carr et al. | Induced alkalosis and caffeine supplementation: effects on 2,000-m rowing performance | |
| Robertson et al. | Nutritional recommendations for synchronized swimming | |
| Burkeb | Practical nutritional recommendations for the athlete | |
| CN105495582A (en) | Anti-fatigue and restorative health-care food amino acid composition | |
| Aly et al. | The effect of honey supplementation formula on delaying some fatigue markers on 1500 meters runners with no impact on performance | |
| WO2014209166A1 (en) | Composition and method for improving mobilizational reserves of the body | |
| JP6478307B2 (en) | Mitochondrial activator | |
| Hannon et al. | Nutritional strategies to support young athletes | |
| Binder | Weight management, nutrition and energy needs for Gymnastics | |
| Score | Have an account? | |
| Palak et al. | Influence of physical training on the function of Autonomic nervous system in professional swimmers | |
| Senchina | Beyond Ginseng And Echinacea: A Meta-analysis Of Herbal Supplement Use By Athletes: 3262 Board# 167 June 2 2: 00 PM-3: 30 PM | |
| Itrat et al. | Dietary Pattern Analysis in Different Types of Sports Activity | |
| Mędyk et al. | Impact of Alternative Diets on Athletes: Analyzing Influence on Athletic Performance | |
| Binnie | Sports supplements | |
| Hannon | 15 Nutritional strategies to support | |
| Rezaimanesh et al. | The effect of caffeine on some cardiovascular factors in male student athletes | |
| Lohan | Sports nutrition: Cavernous viewpoints, key perspectives and factors | |
| El-Sabban | Sports Nutrition: An Evolved Multidisciplinary Field for Athletes | |
| Geyer et al. | Pre-competition cardiac screening in professional handball players–setting up at the EHF European Handball Championship 2010 in Austria | |
| Lamoreau et al. | Can Herbs Improve Endurance? Adaptogens and Athletic Performance | |
| Dobrovolsky et al. | Specifics of carbohydrate metabolism under sport-specific aerobic workloads | |
| Sarkar et al. | Effect of Carbohydrate Consumption on the Performance of Selected Motor Ability on University Players | |
| Leaf | Dairy milk as an ergogenic aid: assessing athletic performance and perceptions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14817174 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 201500990 Country of ref document: EA Ref document number: A201510487 Country of ref document: UA |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14817174 Country of ref document: EP Kind code of ref document: A1 |